Arrowhead Research Corporation (NASDAQ:ARWR) …
(read the story…)

People who looked at this item also looked at…

• Arrowhead Research Subsidiary, Calando Pharmaceuticals, Provides First Proof Of RNA Interference In Humans With … (PharmaceuticalOnline)
• donga.com[English donga] (donga.com)
• Calando Pharmaceuticals demonstrates first targeted siRNA-containing nanoparticle delivery to tumors in humans (News-Medical-Net)
• A Big Breakthrough in Cancer Treatment Via Nanotechnology (Tonic)

Related items

• Arrowhead Research Subsidiary, Calando Pharmaceuticals, Provides First Proof Of RNA Interference In Humans With … (PharmaceuticalOnline)
• Arrowhead Receives Additional 180-Day Grace Period to Comply with the NASDAQ $1.00 Minimum Bid Requirement (Business Wire via Yahoo! Finance)
• Arrowhead seeks to regain Nasdaq compliance (Whittier Daily News)
• Arrowhead Reports Fiscal 2009 Fourth Quarter and Full-Year Financial Results (Business Wire via Yahoo! Finance)
• Calando Pharmaceuticals demonstrates first targeted siRNA-containing nanoparticle delivery to tumors in humans (News-Medical-Net)

Tags: Arrowhead, arrowhead research, ARWR, Corporation, nano, nanotech, nanotechnology, nasdaq, Research, Technology

This entry was posted on December 23, 2009 at 5:00 am and is filed under Business.